IDEAS home Printed from
MyIDEAS: Login

Citations for "The governance of innovation: Vertical integration and collaborative arrangements in the biotechnology industry"

by Pisano, Gary P.

For a complete description of this item, click here. For a RSS feed for citations of this item, click here.
as in new window

  1. Gans, Joshua S. & Stern, Scott, 2003. "The product market and the market for "ideas": commercialization strategies for technology entrepreneurs," Research Policy, Elsevier, vol. 32(2), pages 333-350, February.
  2. Mostak Ahamed Galib & Kamrun Nahar Munny, 2015. "The Inclusion of Academicians into the Industry Sector in Bangladesh: A Model of Industry Engagement and Effective Innovation Performance," International Journal of Management Science and Business Administration, Inovatus Services Ltd., vol. 1(6), pages 7-18, May.
  3. Luigi Orsenigo & Fabio Pammolli & Massimo Riccaboni, 1999. "Competencies, Technological Change and Network Dynamics. The case of the bio-pharmaceutical industry," LEM Papers Series 1999/13, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  4. Joshua S. Gans & David H. Hsu & Scott Stern, 2002. "When Does Start-Up Innovation Spur the Gale of Creative Destruction?," RAND Journal of Economics, The RAND Corporation, vol. 33(4), pages 571-586, Winter.
  5. Johannes Meuer & Christian Rupietta & Uschi Backes-Gellner, 2015. "Layers of co-existing innovation systems," Economics of Education Working Paper Series 0105, University of Zurich, Institute for Strategy and Business Economics (ISU).
  6. Elizabeth Webster & Paul H. Jensen, 2011. "Do Patents Matter for Commercialization?," Journal of Law and Economics, University of Chicago Press, vol. 54(2), pages 431 - 453.
  7. Najib Harabi, 2002. "The Impact of Vertical R&D Cooperation on Firm Innovation: An Empirical Investigation," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 11(2), pages 93-108.
  8. Häussler, Carolin, 2006. "Can’t Buy Me Rights! The Contractual Structure of Asymmetrical Inter-firm Collaborations," Discussion Paper Series of SFB/TR 15 Governance and the Efficiency of Economic Systems 189, Free University of Berlin, Humboldt University of Berlin, University of Bonn, University of Mannheim, University of Munich.
  9. Greis, Noel P. & Dibner, Mark D. & Bean, Alden S., 1995. "External partnering as a response to innovation barriers and global competition in biotechnology," Research Policy, Elsevier, vol. 24(4), pages 609-630, July.
  10. Ajay Agrawal & Iain Cockburn & Laurina Zhang, 2015. "Deals not done: Sources of failure in the market for ideas," Strategic Management Journal, Wiley Blackwell, vol. 36(7), pages 976-986, 07.
  11. Wang, Kai & Hong, Jin & Marinova, Dora & Zhu, Liang, 2009. "Evolution and governance of the biotechnology and pharmaceutical industry of China," Mathematics and Computers in Simulation (MATCOM), Elsevier, vol. 79(9), pages 2947-2956.
  12. Kim, Jerry W. & Higgins, Monica C., 2007. "Where do alliances come from?: The effects of upper echelons on alliance formation," Research Policy, Elsevier, vol. 36(4), pages 499-514, May.
  13. McCann, Brian T. & Folta, Timothy B., 2011. "Performance differentials within geographic clusters," Journal of Business Venturing, Elsevier, vol. 26(1), pages 104-123, January.
  14. Hoenig, Daniel & Henkel, Joachim, 2015. "Quality signals? The role of patents, alliances, and team experience in venture capital financing," Research Policy, Elsevier, vol. 44(5), pages 1049-1064.
  15. Luukkonen, Terttu, 2002. "Technology and market orientation in company participation in the EU framework programme," Research Policy, Elsevier, vol. 31(3), pages 437-455, March.
  16. Kerstin Press, 2006. "Divide to conquer? The Silicon Valley - Boston 128 case revisited," Papers in Evolutionary Economic Geography (PEEG) 0610, Utrecht University, Section of Economic Geography, revised Dec 2006.
  17. Boardman, P. Craig & Corley, Elizabeth A., 2008. "University research centers and the composition of research collaborations," Research Policy, Elsevier, vol. 37(5), pages 900-913, June.
  18. Tahvanainen, Antti-Jussi, 2004. "Academic Spin-offs in Finnish Biotechnology," Discussion Papers 900, The Research Institute of the Finnish Economy.
  19. Dushnitsky, Gary & Lenox, Michael J., 2005. "When do incumbents learn from entrepreneurial ventures?: Corporate venture capital and investing firm innovation rates," Research Policy, Elsevier, vol. 34(5), pages 615-639, June.
  20. Sobrero, Maurizio & Roberts, Edward B., 2002. "Strategic management of supplier-manufacturer relations in new product development," Research Policy, Elsevier, vol. 31(1), pages 159-182, January.
  21. Uwe Cantner & Bastian Rake, 2011. "International Research Networks in Pharmaceuticals: Structure and Dynamics," Jena Economic Research Papers 2011-055, Friedrich-Schiller-University Jena.
  22. David B. Audretsch & Dennis P. Leyden & Albert N. Link, 2012. "Universities as research partners in publicly supported entrepreneurial firms," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 21(5-6), pages 529-545, December.
  23. Tapon, Francis & Cadsby, Charles Bram, 1996. "The optimal organization of research: evidence from eight case studies of pharmaceutical firms," Journal of Economic Behavior & Organization, Elsevier, vol. 31(3), pages 381-399, December.
  24. Harabi, Najib, 1997. "Vertical Relations Between Firms and Innovation: An Empirical Investigation of German Firms," ZEW Discussion Papers 97-10, ZEW - Zentrum für Europäische Wirtschaftsforschung / Center for European Economic Research.
  25. Benjamin Clark, 2011. "Influences and conflicts of federal policies in academic–industrial scientific collaboration," The Journal of Technology Transfer, Springer, vol. 36(5), pages 514-545, October.
  26. Luo, Xiaowei Rose & Koput, Kenneth W. & Powell, Walter W., 2009. "Intellectual capital or signal? The effects of scientists on alliance formation in knowledge-intensive industries," Research Policy, Elsevier, vol. 38(8), pages 1313-1325, October.
  27. Klaus Kultti & Tuomas Takalo & Tanja Tanayama, 2015. "R&D spillovers and information exchange: a case study," Eurasian Economic Review, Eurasia Business and Economics Society, vol. 5(1), pages 63-76, June.
  28. Franco Malerba & Luigi Orsenigo, 2000. "Towards a History Friendly Model of Innovation, Market Structure and Regulation in the Dynamics of the Pharmaceutical Industry: the Age of Random Screening," KITeS Working Papers 124, KITeS, Centre for Knowledge, Internationalization and Technology Studies, Universita' Bocconi, Milano, Italy, revised Jan 2001.
  29. Paola Giuri & John Hagedoorn & Myriam Mariani, 2002. "Technological Diversification and Strategic Alliances," LEM Papers Series 2002/04, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  30. Colombo, Massimo G. & Grilli, Luca & Piva, Evila, 2006. "In search of complementary assets: The determinants of alliance formation of high-tech start-ups," Research Policy, Elsevier, vol. 35(8), pages 1166-1199, October.
  31. Luukkonen, Terttu, 2003. "Variability in Forms of Organisation in Biotechnology Firms," Discussion Papers 872, The Research Institute of the Finnish Economy.
  32. Kamrun Nahar Munny & Mostak Ahamed Galib & Ding Lin, 2015. "Scientists Collaborating with Industry: An Exploration of Industry Engagement Types," International Journal of Management Science and Business Administration, Inovatus Services Ltd., vol. 1(8), pages 37-46, July.
  33. Kollmer, Holger & Dowling, Michael, 2004. "Licensing as a commercialisation strategy for new technology-based firms," Research Policy, Elsevier, vol. 33(8), pages 1141-1151, October.
  34. Hagedoorn,John, 2000. "External Appropriation of Innovative Capabilities: The Preference for Strategic Alliances or M&AS," Research Memorandum 008, Maastricht University, Maastricht Economic Research Institute on Innovation and Technology (MERIT).
  35. Orsenigo, L. & Pammolli, F. & Riccaboni, Massimo, 2001. "Technological change and network dynamics: Lessons from the pharmaceutical industry," Research Policy, Elsevier, vol. 30(3), pages 485-508, March.
  36. Li, Dan, 2013. "Multilateral R&D alliances by new ventures," Journal of Business Venturing, Elsevier, vol. 28(2), pages 241-260.
  37. Hermano, Víctor & Martín-Cruz, Natalia, 2013. "How to Deliver Foreign Aid? The Case of Projects Governed by the Spanish International Agency," World Development, Elsevier, vol. 43(C), pages 298-314.
  38. Roijakkers, Nadine & Hagedoorn, John & van Kranenburg, Hans, 2005. "Dual market structures and the likelihood of repeated ties - evidence from pharmaceutical biotechnology," Research Policy, Elsevier, vol. 34(2), pages 235-245, March.
  39. Versaevel, Bruno & de Villemeur, Étienne, 2003. "Conflict and Cooperation on R&D Markets," IDEI Working Papers 191, Institut d'Économie Industrielle (IDEI), Toulouse.
  40. Marcela Miozzo & Lori DiVito & Panos Desyllas, 2011. "Cross-border acquisitions of science-based firms: Their effect on innovation in the acquired firm and the local science," DRUID Working Papers 11-17, DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies.
  41. Bercovitz, Janet E.L. & Feldman, Maryann P., 2007. "Fishing upstream: Firm innovation strategy and university research alliances," Research Policy, Elsevier, vol. 36(7), pages 930-948, September.
  42. Rothaermel, Frank T., 2001. "Complementary assets, strategic alliances, and the incumbent's advantage: an empirical study of industry and firm effects in the biopharmaceutical industry," Research Policy, Elsevier, vol. 30(8), pages 1235-1251, October.
  43. Annika Rickne, 2006. "Connectivity and Performance of Science-based Firms," Small Business Economics, Springer, vol. 26(4), pages 393-407, 05.
  44. Czarnitzki, Dirk & Hottenrott, Hanna, 2012. "Collaborative R&D as a strategy to attenuate financing constraints," ZEW Discussion Papers 12-049, ZEW - Zentrum für Europäische Wirtschaftsforschung / Center for European Economic Research.
  45. BELDERBOS, René & GILSING, Victor & SUZUKI, Shinya, 2015. "Direct And Mediated Ties To Universities: ‘Scientific’ Absorptive Capacity And Innovation Performance Of Pharmaceutical Firms," Discussion paper series 2015-06, Hitotsubashi Institute for Advanced Study, Hitotsubashi University.
  46. Sobrero, Maurizio. & Roberts, Edward Baer., 1996. "The trade-off between efficiency and learning in inter-organizational relationships," Working papers 3896-96., Massachusetts Institute of Technology (MIT), Sloan School of Management.
  47. Avenel, E. & Corolleur, F. & Gauthier, C. & Rieu, C., 2005. "Start-ups, firm growth and the consolidation of the French biotech industry," Working Papers 200503, Grenoble Applied Economics Laboratory (GAEL).
  48. Bozeman, Barry & Corley, Elizabeth, 2004. "Scientists' collaboration strategies: implications for scientific and technical human capital," Research Policy, Elsevier, vol. 33(4), pages 599-616, May.
  49. Luukkonen, Terttu, 2005. "Variability in organisational forms of biotechnology firms," Research Policy, Elsevier, vol. 34(4), pages 555-570, May.
This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.